WASHINGTON -- The Food and Drug Administration (FDA) has cleared for use by the U.S. military a liquid decontamination lotion intended to remove or neutralize chemical warfare agents and T-2 fungal toxin from the skin.
The lotion, called Reactive Skin Decontamination Lotion (RSDL), must be applied to exposed skin as soon as possible after exposure to a chemical agent.
The lotion is impregnated in a sponge pad packaged as a single unit in a heat-sealed foil pouch. When exposed to chemical warfare agents, the user wipes the exposed skin with the lotion. The lotion removes the agents or the T-2 toxin and also reacts with the chemical agents, rapidly neutralizing them so they are non-toxic.
"If used in time, this lotion can help prevent the serious burns and deaths that results from exposure to chemical warfare agents," said FDA Commissioner Mark B. McClellan, MD, PhD. "FDA worked with the U.S. Army to expedite review of this product to make it available to our men and women in uniform as quickly as possible."
FDA cleared the lotion for use based on studies conducted by the U.S. Department of the Army that showed it is safe and effective. The Army tested the product's safety by conducting skin irritation, sensitization and photo irritation studies in more than 300 people. It tested its effectiveness by using it to treat animals that had been exposed to chemical agents. The Canadian military and the U.S. military worked together to develop the scientific data on which FDA based clearance of the product.
RSDL is manufactured by O'Dell Engineering Ltd/E-Z-EM Canada Inc., Canada.
Source: FDA
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.